The Prostate Cancer Clinical Trials Consortium Selects WIRB-Copernicus
Published on:
Applied Clinical Trials
PCCTC will utilize its services for the review of its cancer research protocols and related study documents.
WIRB-Copernicus Group, a provider of regulatory and ethical review services and software to support clinical research, and the Prostate Cancer Clinical Trials Consortium (PCCTC), a multicenter clinical research organization specializing in cutting-edge prostate cancer research, announced PCCTC will utilize its services for the review of its cancer research protocols and related study documents. This is a significant change for PCCTC, which previously relied on its members’ local IRBs.
